Skip to Navigation Skip to Search Skip to Content
Search All Centers

Does Cytoreductive Therapy Reduce the Risk of Blood Clots in MPNs?

Published on June 20, 2016

Patient Power community member, Joan, asks, â??What is cytoreductive therapy, and does it reduce the risk of blood clots?â?? Dr. Mark Heaney of Columbia University Medical Center answers this question by defining cytoreduction and by providing background information related to clinical trial results. Listen as Dr. Heaney discusses the role of cytoreductive therapy in the treatment of essential thrombocythemia (ET).

The Ask the Expert series is sponsored through an educational grant to the Patient Empowerment Network from Incyte Corporation.

Featuring

Sponsors

Patient Empowerment Network

You might also like